» Articles » PMID: 22923963

Effect of Hydroalcoholic Extract of Hypericum Perforatum on Selected Traditional and Novel Biochemical Factors of Cardiovascular Diseases and Atherosclerotic Lesions in Hypercholesterolemic Rabbits: A Comparison Between the Extract and Lovastatin

Overview
Specialty Pharmacology
Date 2012 Aug 28
PMID 22923963
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Evidence suggests that diets with high contents of cholesterol will increase serum lipoproteins and apolipoproteins, thereby increase risk of atherosclerosis. According to literature, some plants show hypolipidemic, hypocholestrolemic, and antiatherosclerotic activities.

Aims: In this study, antiatherosclerotic effect of Hypericum perforatum hydroalcoholic extract on hypercholesterolemic rabbits was compared with that of lovastatin.

Materials And Methods: Twenty five mature male New Zealand rabbits were randomly divided into five groups of five and were fed for 60 days as follows: Standard diet (GroupI), standard diet and hydroalcoholic extract of Hypericum perforatum (150 mg/kg daily)(GroupII), standard diet, hydroalcoholic extract of Hypericum perforatum (150 mg/ kg daily) and cholesterol (1% of food content) (Group III), standard diet and cholesterol (1% of food content)(GroupIV), and finally standard diet, lovastatin (10 mg/kg), and cholesterol (1% of foodcontent) (GroupV).

Results: Hypericum perforatum extract significantly decreased the levels of apolipoprotein B(apoB), apolipoprotein B/apolipoprotein A (apoB/apoA), triglyceride, cholesterol, low density lipoprotein cholesterol, oxidized LDL, malondialdehyde, and C-reactive protein (CRP) as well as atherosclerosis index, and increased high density lipoprotein and apoA in rabbits of Group III compared to the rabbits of Group IV. The effect of Hypericum perforatum extract in decreasing the level of some biochemical factors like apoB, apoB/apoA, and CRP was meaningfully more than that of lovastatin. Histopathological findings confirmed that hydroalcoholic extract of Hypericum perforatum restricted the atherosclerotic lesions.

Conclusions: This study indicates that hydroalcoholic extract of Hypericum perforatum possesses hypolipidemic and anti-atherosclerotic effects and could be beneficial in the management of hyperlipidemia and atherosclerosis.

Citing Articles

L. and the Underlying Molecular Mechanisms for Its Choleretic, Cholagogue, and Regenerative Properties.

Mohagheghzadeh A, Badr P, Mohagheghzadeh A, Hemmati S Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375834 PMC: 10300974. DOI: 10.3390/ph16060887.


Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects.

Zhang Q, Wang F, Jia K, Kong L Front Pharmacol. 2018; 9:1253.

PMID: 30459615 PMC: 6232953. DOI: 10.3389/fphar.2018.01253.


Population-based Cohort Study in Outcome of Phased Progression of Atherosclerosis in China (PERSUADE): objective, rationale and design.

Shan D, Zhou Y, Wang Y, Gao X, Wang W, Yang J J Geriatr Cardiol. 2017; 14(8):491-495.

PMID: 29089964 PMC: 5653894. DOI: 10.11909/j.issn.1671-5411.2017.08.001.


Effect of Hypericum perforatum Aqueous Extracts on Serum Lipids, Aminotransferases, and Lipid Peroxidation in Hyperlipidemic Rats.

Ghosian Moghaddam M, Roghani M, Maleki M Res Cardiovasc Med. 2016; 5(2):e31326.

PMID: 26949689 PMC: 4756258. DOI: 10.5812/cardiovascmed.31326.


Nuclear receptors in vascular biology.

Bishop-Bailey D Curr Atheroscler Rep. 2015; 17(5):507.

PMID: 25772409 DOI: 10.1007/s11883-015-0507-8.


References
1.
Draper H, Hadley M . Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990; 186:421-31. DOI: 10.1016/0076-6879(90)86135-i. View

2.
Kaplan M, Aviram M . Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin Chem Lab Med. 1999; 37(8):777-87. DOI: 10.1515/CCLM.1999.118. View

3.
Chekanov V . Low frequency electrical impulses reduce atherosclerosis in cholesterol fed rabbits. Med Sci Monit. 2003; 9(8):BR302-9. View

4.
Elias-Smale S, Kardys I, Oudkerk M, Hofman A, Witteman J . C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis. 2007; 195(2):e195-202. DOI: 10.1016/j.atherosclerosis.2007.07.006. View

5.
Canto J, Iskandrian A . Major risk factors for cardiovascular disease: debunking the "only 50%" myth. JAMA. 2003; 290(7):947-9. DOI: 10.1001/jama.290.7.947. View